Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions

The use of treatable traits to address COPD complexity and heterogeneity and to inform the care

Katarzyna Duszyk, Rebecca F. McLoughlin, Peter G. Gibson, Vanessa M. McDonald
Breathe 2021 17: 210118; DOI: 10.1183/20734735.0118-2021
Katarzyna Duszyk
1National Health and Medical Research Council Centre of Excellence in Treatable Traits and Priority Research Centre for Healthy Lungs, the University of Newcastle, Newcastle, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebecca F. McLoughlin
1National Health and Medical Research Council Centre of Excellence in Treatable Traits and Priority Research Centre for Healthy Lungs, the University of Newcastle, Newcastle, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter G. Gibson
1National Health and Medical Research Council Centre of Excellence in Treatable Traits and Priority Research Centre for Healthy Lungs, the University of Newcastle, Newcastle, Australia
2Dept of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter G. Gibson
Vanessa M. McDonald
1National Health and Medical Research Council Centre of Excellence in Treatable Traits and Priority Research Centre for Healthy Lungs, the University of Newcastle, Newcastle, Australia
2Dept of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vanessa M. McDonald
  • For correspondence: vanessa.mcdonald@newcastle.edu.au
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 17 no. 4
DOI 
https://doi.org/10.1183/20734735.0118-2021

Published By 
European Respiratory Society
Print ISSN 
1810-6838
Online ISSN 
2073-4735
History 
  • Received August 3, 2021
  • Accepted November 11, 2021
  • Published online January 11, 2022.

Copyright & Usage 
Copyright ©ERS 2022 Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Author Information

  1. Katarzyna Duszyk1,
  2. Rebecca F. McLoughlin1,
  3. Peter G. Gibson1,2 and
  4. Vanessa M. McDonald1,2⇑
  1. 1National Health and Medical Research Council Centre of Excellence in Treatable Traits and Priority Research Centre for Healthy Lungs, the University of Newcastle, Newcastle, Australia
  2. 2Dept of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, Australia
  1. Corresponding author: Vanessa M. McDonald (vanessa.mcdonald{at}newcastle.edu.au)
View Full Text

Article usage

Article usage: January 2022 to May 2022

AbstractFullPdf
Jan 20229670235
Feb 202213349150
Mar 20221528078
Apr 20221117062
May 202268848

Altmetrics

PreviousNext
Back to top
Vol 17 Issue 4 Table of Contents
Breathe: 17 (4)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The use of treatable traits to address COPD complexity and heterogeneity and to inform the care
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
The use of treatable traits to address COPD complexity and heterogeneity and to inform the care
Katarzyna Duszyk, Rebecca F. McLoughlin, Peter G. Gibson, Vanessa M. McDonald
Breathe Dec 2021, 17 (4) 210118; DOI: 10.1183/20734735.0118-2021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The use of treatable traits to address COPD complexity and heterogeneity and to inform the care
Katarzyna Duszyk, Rebecca F. McLoughlin, Peter G. Gibson, Vanessa M. McDonald
Breathe Dec 2021, 17 (4) 210118; DOI: 10.1183/20734735.0118-2021
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Educational aims
    • Introduction
    • Heterogeneity and natural history of COPD
    • Treatable traits, a precision medicine approach for chronic airway disease management: the evidence
    • Implementation of the treatable traits strategy across different settings
    • Future
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory clinical practice
  • COPD and smoking
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Sleep disorders in pregnancy
  • Management of pregnancy in cystic fibrosis
  • Non-COVID-19 respiratory viral infection
Show more Reviews

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About Breathe

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Intructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 1810-6838
Online ISSN: 2073-4735

Copyright © 2022 by the European Respiratory Society